Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,293-2,304 of 4,306
Behavioral study icon
CompletedNCT01279070

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Sant Boi de Llobregat
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
Spain
Sponsor
Fundació Sant Joan de Déu
Condition
Schizophrenia
Drug study icon
CompletedNCT00810667

Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Liège
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
France, Belgium, Germany, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Drug study icon
CompletedNCT01393613

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Colombia, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00761670

Efficacy Study on Cognitive Functions in Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Budapest
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Hungary
Sponsor
Sanofi
Condition
Schizophrenia
Drug study icon
CompletedNCT02477670

Efficacy, Safety, and Tolerability of AVP-786 for Residual Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01668797

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Colombia, Malaysia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.